This document is an excerpt from the EUR-Lex website
Document 02016R0127-20230317
Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding (Text with EEA relevance)Text with EEA relevance
Consolidated text: Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding (Text with EEA relevance)Text with EEA relevance
Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding (Text with EEA relevance)Text with EEA relevance
This consolidated text may not include the following amendments:
| Amending act | Amendment type | Subdivision concerned | Date of effect |
|---|---|---|---|
| 32024R2684 | Modified by | annex II point 2.3 | 11/10/2024 |
| 32024R2684 | Modified by | annex I point 2.3 | 11/10/2024 |
| 32024R2684 | Modified by | annex III section A sentence | 11/10/2024 |
02016R0127 — EN — 17.03.2023 — 006.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
|
COMMISSION DELEGATED REGULATION (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding (OJ L 025 2.2.2016, p. 1) |
Amended by:
|
|
|
Official Journal |
||
|
No |
page |
date |
||
|
COMMISSION DELEGATED REGULATION (EU) 2018/561 of 29 January 2018 |
L 94 |
1 |
12.4.2018 |
|
|
COMMISSION DELEGATED REGULATION (EU) 2019/828 of 14 March 2019 |
L 137 |
12 |
23.5.2019 |
|
|
COMMISSION DELEGATED REGULATION (EU) 2021/572 of 20 January 2021 |
L 120 |
4 |
8.4.2021 |
|
|
COMMISSION DELEGATED REGULATION (EU) 2021/1041 of 16 April 2021 |
L 225 |
4 |
25.6.2021 |
|
|
COMMISSION DELEGATED REGULATION (EU) 2022/519 of 14 January 2022 |
L 104 |
58 |
1.4.2022 |
|
|
COMMISSION DELEGATED REGULATION (EU) 2023/589 of 10 January 2023 |
L 79 |
40 |
17.3.2023 |
|
COMMISSION DELEGATED REGULATION (EU) 2016/127
of 25 September 2015
supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding
(Text with EEA relevance)
Article 1
Placing on the market
Article 2
Compositional requirements
Article 3
Suitability of ingredients
Article 4
Requirements on pesticides
Those levels shall be determined by generally accepted standardised analytical methods.
However, for the purpose of checks, plant protection products containing the active substances listed in Annex V are considered not to have been used if their residues do not exceed a level of 0,003 mg/kg.
Article 5
Name of the food
Article 6
Specific requirements on food information
In addition to the mandatory particulars listed in Article 9(1) of Regulation (EU) No 1169/2011, the following shall be additional mandatory particulars for infant formula:
a statement that the product is suitable for infants from birth when they are not breast fed;
instructions for appropriate preparation, storage and disposal of the product and a warning against the health hazards of inappropriate preparation and storage;
a statement concerning the superiority of breast feeding and a statement recommending that the product be used only on the advice of independent persons having qualifications in medicine, nutrition or pharmacy, or other professionals responsible for maternal and child care. The particulars referred to in this point shall be preceded by the words ‘important notice’ or their equivalent and shall be given also in the presentation and advertising of infant formula.
In addition to the mandatory particulars listed in Article 9(1) of Regulation (EU) No 1169/2011, the following shall be additional mandatory particulars for follow-on formula:
a statement that the product is suitable only for infants over the age of six months, that it should form only part of a diversified diet, that it is not to be used as a substitute for breast milk during the first six months of life and that the decision to begin complementary feeding, including any exception to six months of age, should be made only on the advice of independent persons having qualifications in medicine, nutrition or pharmacy, or other professionals responsible for maternal and child care, based on the individual infant's specific growth and development needs;
instructions for appropriate preparation, storage and disposal of the product and a warning against the health hazards of inappropriate preparation and storage.
The labelling, presentation and advertising of infant formula and follow-on formula shall not use the terms ‘humanised’, ‘maternalised’, ‘adapted’, or terms similar to them.
The labelling, presentation and advertising of infant formula and follow-on formula shall be designed in such a way that it avoids any risk of confusion between infant formula and follow-on formula and enables consumers to make a clear distinction between them, in particular as to the text, images and colours used.
Article 7
Specific requirements on the nutrition declaration
The mandatory nutrition declaration for infant formula shall also include the amount of choline, inositol and carnitine.
By way of derogation from Article 30(1) of Regulation (EU) No 1169/2011, the mandatory nutrition declaration for infant formula and follow-on formula shall not include the amount of salt.
In addition to the information referred to in Article 30(2)(a) to (e) of Regulation (EU) No 1169/2011, the content of the mandatory nutrition declaration for infant formula and follow-on formula may be supplemented with one or more of the following:
the amounts of components of protein, carbohydrate or fat;
the whey protein/casein ratio;
the amount of any of the substances listed in Annex I or Annex II to this Regulation or in the Annex to Regulation (EU) No 609/2013, where the indication of any of those substances is not covered by paragraph 1;
the amount of any of the substances added to the product pursuant to Article 3.
In addition to the form of expression referred to in paragraph 6, in the case of follow-on formula, the declaration on vitamins and minerals in respect of the vitamins and minerals listed in Annex VII to this Regulation may be expressed as a percentage of the reference intakes set out in that Annex in relation to per 100 ml of the food ready for use after preparation in accordance with the manufacturer's instructions.
Particulars not listed in Annex XV to Regulation (EU) No 1169/2011 that do not belong to or are not components of any of the entries of that Annex shall be presented in the nutrition declaration after the last entry of that Annex.
Article 8
Nutrition and health claims for infant formula
Nutrition and health claims shall not be made on infant formula.
Article 9
Statements related to lactose and docosahexaenoic acid (DHA)
When the statement ‘lactose free’ is used for infant formula and follow-on formula manufactured from protein sources other than soya protein isolates, it shall be accompanied by the statement ‘not suitable for infants with galactosaemia’, which shall be indicated with the same font size and prominence as the statement ‘lactose free’ and in close proximity to it.
Article 10
Requirements for promotional and commercial practices for infant formula
Member States may further restrict or prohibit such advertising. Such advertising shall contain only information of a scientific and factual nature. Such information shall not imply or create a belief that bottle-feeding is equivalent or superior to breast feeding.
Article 11
Requirements on information relating to infant and young child feeding
Informational and educational materials, whether written or audiovisual, dealing with the feeding of infants and intended to reach pregnant women and mothers of infants and young children, shall include clear information on all the following points:
the benefits and superiority of breast feeding;
maternal nutrition and the preparation for and maintenance of breast feeding;
the possible negative effect on breast feeding of introducing partial bottle feeding;
the difficulty of reversing the decision not to breast feed;
where needed, the proper use of infant formula.
Where such materials contain information about the use of infant formula, they shall include the social and financial implications of its use, the health hazards of inappropriate foods or feeding methods, and, in particular, the health hazards of improper use of infant formula. Such material shall not use any pictures which may idealise the use of infant formula.
Article 12
Notification
Article 13
Directive 2006/141/EC
In accordance with Article 20(4) of Regulation (EU) No 609/2013, Directive 2006/141/EC is repealed with effect from 22 February 2020. However, Directive 2006/141/EC shall continue to apply until 21 February 2022 to infant formula and follow-on formula manufactured from protein hydrolysates
References to Directive 2006/141/EC in other acts shall be construed as references to this Regulation in accordance with the scheme set out in the first paragraph.
Article 14
Entry into force and application
This Regulation shall enter into force on the 20th day following that of its publication in the Official Journal of the European Union.
It shall apply from 22 February 2020, except in respect of infant formula and follow-on formula manufactured from protein hydrolysates, to which it shall apply from 22 February 2022.
For the purposes of the second subparagraph of Article 21(1) of Regulation (EU) No 609/2013, in respect of infant formula and follow-on formula manufactured from protein hydrolysates the later date referred to in the second paragraph of this Article shall be considered as the date of application.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX I
COMPOSITIONAL REQUIREMENTS REFERRED TO IN ARTICLE 2(1)
1. ENERGY
|
Minimum |
Maximum |
|
250 kJ/100 ml |
293 kJ/100 ml |
|
(60 kcal/100 ml) |
(70 kcal/100 ml) |
2. PROTEINS
(Protein content = nitrogen content × 6,25)
2.1. Infant formula manufactured from cows' milk or goats' milk proteins
|
Minimum |
Maximum |
|
0,43 g/100 kJ |
0,6 g/100 kJ |
|
(1,8 g/100 kcal) |
(2,5 g/100 kcal) |
For an equal energy value, infant formula manufactured from cows' milk or goats' milk proteins must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine:cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
2.2. Infant formula manufactured from soya protein isolates, alone or in a mixture with cows' milk or goats' milk proteins
|
Minimum |
Maximum |
|
0,54 g/100 kJ |
0,67 g/100 kJ |
|
(2,25 g/100 kcal) |
(2,8 g/100 kcal) |
Only protein isolates from soya shall be used in manufacturing this infant formula.
For an equal energy value, infant formula manufactured from soya protein isolates, alone or in a mixture with cows' milk or goats' milk proteins, must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine:cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
2.3. Infant formula manufactured from protein hydrolysates
Infant formula manufactured from protein hydrolysates shall comply with the protein-related requirements provided under point 2.3.1, point 2.3.2, or point 2.3.3.
Protein-related requirements group A
Protein content
|
Minimum |
Maximum |
|
0,44 g/100 kJ |
0,67 g/100 kJ |
|
(1,86 g/100 kcal) |
(2,8 g/100 kcal) |
Protein source
Demineralised sweet whey protein derived from cows’ milk after enzymatic precipitation of caseins using chymosin, consisting of:
63 % caseino-glycomacropeptide free whey protein isolate with a minimum protein content of 95 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3 %; and
37 % sweet whey protein concentrate with a minimum protein content of 87 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3,5 %.
Protein processing
Two-stage hydrolysis process using a trypsin preparation with a heat-treatment step (from 3 to 10 minutes at 80 to 100 °C) between the two hydrolysis steps.
Indispensable and conditionally indispensable amino acids and L-carnitine
For an equal energy value, infant formula manufactured from protein hydrolysates must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section B of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine:cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
Protein-related requirements group B
Protein content
|
Minimum |
Maximum |
|
0,55 g/100 kJ |
0,67 g/100 kJ |
|
(2,3 g/100 kcal) |
(2,8 g/100 kcal) |
Protein source
Whey protein derived from cows’ milk, consisting of:
77 % acid whey, coming from whey protein concentrate with a protein content of 35 to 80 %;
23 % sweet whey, coming from demineralised sweet whey with a minimum protein content of 12,5 %.
Protein processing
The source material is hydrated and heated. Following the heat-treatment step, the hydrolysis is carried out at a pH of 7,5 to 8,5 and a temperature of 55 to 70 °C with the use of an enzyme mixture of a serine endopeptidase and a protease/peptidase complex. The food enzymes are inactivated in a heat treatment step (from 2 to 10 seconds at 120 to 150 °C) during the production process.
Indispensable and conditionally indispensable amino acids and L-carnitine
For an equal energy value, infant formula manufactured from protein hydrolysates must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine: cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
Protein-related requirements group C
Protein content
|
Minimum |
Maximum |
|
0,45 g/100 kJ |
0,67 g/100 kJ |
|
(1,9 g/100 kcal) |
(2,8 g/100 kcal) |
Protein source
Whey protein derived from cows’ milk, consisting of 100 % sweet whey protein concentrate with a minimum protein content of 80 %.
Protein processing
The source material is hydrated and heated. Prior to the hydrolysis, the pH is adjusted to 6,5–7,5 at a temperature of 50–65 °C. The hydrolysis is carried out with the use of an enzyme mixture of a serine endopeptidase and a metalloprotease. The food enzymes are inactivated in a heat treatment step (from 2 to 10 seconds at 110 to 140 °C) during the production process.
Indispensable and conditionally indispensable amino acids and L-carnitine
For an equal energy value, infant formula manufactured from protein hydrolysates must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine: cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
|
2.4. |
In all cases, amino acids may be added to infant formula solely for the purpose of improving the nutritional value of the proteins, and only in the proportions necessary for that purpose. |
3. TAURINE
If added to infant formula, the amount of taurine shall not be greater than 2,9 mg/100 kJ (12 mg/100 kcal).
4. CHOLINE
|
Minimum |
Maximum |
|
6,0 mg/100 kJ |
12 mg/100 kJ |
|
(25 mg/100 kcal) |
(50 mg/100 kcal) |
5. LIPIDS
|
Minimum |
Maximum |
|
1,1 g/100 kJ |
1,4 g/100 kJ |
|
(4,4 g/100 kcal) |
(6,0 g/100 kcal) |
|
5.1. |
The use of the following substances shall be prohibited:
—
sesame seed oil,
—
cotton seed oil.
|
|
5.2. |
The trans fatty acid content shall not exceed 3 % of the total fat content. |
|
5.3. |
The erucic acid content shall not exceed 0,4 % of the total fat content. |
|
5.4. |
Linoleic acid
|
|
5.5. |
Alpha-linolenic acid
|
|
5.6. |
Docosahexaenoic acid
|
|
5.7. |
Other long-chain (20 and 22 carbon atoms) polyunsaturated fatty acids may be added. In that case the content of long-chain polyunsaturated fatty acids shall not exceed 2 % of the total fat content for n-6 long-chain polyunsaturated fatty acids (1 % of the total fat content for arachidonic acid (20:4 n-6)). The eicosapentaenoic acid (20:5 n-3) content shall not exceed that of docosahexaenoic (22:6 n-3) acid content. |
6. PHOSPHOLIPIDS
The amount of phospholipids in infant formula shall not be greater than 2 g/l.
7. INOSITOL
|
Minimum |
Maximum |
|
0,96 mg/100 kJ |
9,6 mg/100 kJ |
|
(4 mg/100 kcal) |
(40 mg/100 kcal) |
8. CARBOHYDRATES
|
Minimum |
Maximum |
|
2,2 g/100 kJ |
3,3 g/100 kJ |
|
(9 g/100 kcal) |
(14 g/100 kcal) |
|
8.1. |
Only the following carbohydrates may be used:
—
lactose,
—
maltose,
—
sucrose,
—
glucose,
—
glucose syrup or dried glucose syrup,
—
malto-dextrins,
—
pre-cooked starch (naturally free of gluten),
—
gelatinised starch (naturally free of gluten).
|
|
8.2. |
Lactose
Those minimum levels shall not apply to infant formula:
—
in which soya protein isolates represent more than 50 % of the total protein content, or
—
bearing the statement ‘lactose free’ in accordance with Article 9(2).
|
|
8.3. |
Sucrose Sucrose may only be added to infant formula manufactured from protein hydrolysates. If added, the sucrose content shall not exceed 20 % of the total carbohydrate content. |
|
8.4. |
Glucose Glucose may only be added to infant formula manufactured from protein hydrolysates. If added, the glucose content shall not exceed 0,5 g/100 kJ (2 g/100 kcal). |
|
8.5. |
Glucose syrup or dried glucose syrup Glucose syrup or dried glucose syrup may be added to infant formula manufactured from cows' milk or goats' milk proteins or infant formula manufactured from soya protein isolates (alone or in a mixture with cows' milk or goats' milk proteins) only if its dextrose equivalent does not exceed 32. If glucose syrup or dried glucose syrup is added to these products, the glucose content resulting from glucose syrup or dried glucose syrup shall not exceed 0,2 g/100 kJ (0,84 g/100 kcal). The maximum glucose amounts laid down in point 8.4 shall apply if glucose syrup or dried glucose syrup is added to infant formula manufactured from protein hydrolysates. |
|
8.6. |
Pre-cooked starch and/or gelatinised starch
|
9. FRUCTO-OLIGOSACCHARIDES AND GALACTO-OLIGOSACCHARIDES
Fructo-oligosaccharides and galacto-oligosaccharides may be added to infant formula. In that case their content shall not exceed: 0,8 g/100 ml in a combination of 90 % oligogalactosyl-lactose and 10 % high molecular weight oligofructosyl-saccharose.
Other combinations and maximum levels of fructo-oligosaccharides and galacto-oligosaccharides may be used, provided that their suitability for infants is demonstrated in accordance with Article 3(3).
10. MINERAL SUBSTANCES
10.1. Infant formula manufactured from cows' milk or goats' milk proteins or protein hydrolysates
|
|
Per 100 kJ |
Per 100 kcal |
||
|
Minimum |
Maximum |
Minimum |
Maximum |
|
|
Sodium (mg) |
6 |
14,3 |
25 |
60 |
|
Potassium (mg) |
19,1 |
38,2 |
80 |
160 |
|
Chloride (mg) |
14,3 |
38,2 |
60 |
160 |
|
Calcium (mg) |
12 |
33,5 |
50 |
140 |
|
Phosphorus (mg) (1) |
6 |
21,5 |
25 |
90 |
|
Magnesium (mg) |
1,2 |
3,6 |
5 |
15 |
|
Iron (mg) |
0,07 |
0,31 |
0,3 |
1,3 |
|
Zinc (mg) |
0,12 |
0,24 |
0,5 |
1 |
|
Copper (μg) |
14,3 |
24 |
60 |
100 |
|
Iodine (μg) |
3,6 |
6,9 |
15 |
29 |
|
Selenium (μg) |
0,72 |
2 |
3 |
8,6 |
|
Manganese (μg) |
0,24 |
24 |
1 |
100 |
|
Molybdenum (μg) |
— |
3,3 |
— |
14 |
|
Fluoride (μg) |
— |
24 |
— |
100 |
|
(1)
Total phosphorus. |
||||
The calcium:available phosphorus molar ratio shall not be less than 1 nor greater than 2. The amount of available phosphorus shall be calculated as 80 % of total phosphorus for infant formula manufactured from cow's milk protein, goats' milk protein or protein hydrolysates.
10.2. Infant formula manufactured from soya protein isolates, alone or in a mixture with cows' milk or goats' milk proteins
All requirements of point 10.1 shall apply, except for those concerning iron, phosphorus and zinc, which shall be as follows:
|
|
Per 100 kJ |
Per 100 kcal |
||
|
Minimum |
Maximum |
Minimum |
Maximum |
|
|
Iron (mg) |
0,11 |
0,48 |
0,45 |
2 |
|
Phosphorus (mg) (1) |
7,2 |
24 |
30 |
100 |
|
Zinc (mg) |
0,18 |
0,3 |
0,75 |
1,25 |
|
(1)
Total phosphorus. |
||||
The calcium:available phosphorus molar ratio shall not be less than 1 nor greater than 2. The amount of available phosphorus shall be calculated as 70 % of total phosphorus for infant formula manufactured from soya protein isolates.
11. VITAMINS
|
|
Per 100 kJ |
Per 100 kcal |
||
|
Minimum |
Maximum |
Minimum |
Maximum |
|
|
Vitamin A (μg-RE) (1) |
16,7 |
27,2 |
70 |
114 |
|
Vitamin D (μg) |
0,48 |
0,6 |
2 |
2,5 |
|
Thiamine (μg) |
9,6 |
72 |
40 |
300 |
|
Riboflavin (μg) |
14,3 |
95,6 |
60 |
400 |
|
Niacin (mg) (2) |
0,1 |
0,36 |
0,4 |
1,5 |
|
Pantothenic acid (mg) |
0,1 |
0,48 |
0,4 |
2 |
|
Vitamin B6 (μg) |
4,8 |
41,8 |
20 |
175 |
|
Biotin (μg) |
0,24 |
1,8 |
1 |
7,5 |
|
Folate (μg-DFE) (3) |
3,6 |
11,4 |
15 |
47,6 |
|
Vitamin B12 (μg) |
0,02 |
0,12 |
0,1 |
0,5 |
|
Vitamin C (mg) |
0,96 |
7,2 |
4 |
30 |
|
Vitamin K (μg) |
0,24 |
6 |
1 |
25 |
|
Vitamin E (mg α-tocopherol) (4) |
0,14 |
1,2 |
0,6 |
5 |
|
(1)
Preformed vitamin A; RE = all trans retinol equivalent.
(2)
Preformed niacin.
(3)
Dietary folate equivalent: 1 μg DFE = 1 μg food folate = 0,6 μg folic acid from formula.
(4)
Based on vitamin E activity of RRR-α-tocopherol. |
||||
12. NUCLEOTIDES
The following nucleotides may be added:
|
|
Maximum (1) |
|
|
(mg/100 kJ) |
(mg/100 kcal) |
|
|
cytidine 5′-monophosphate |
0,60 |
2,50 |
|
uridine 5′-monophosphate |
0,42 |
1,75 |
|
adenosine 5′-monophosphate |
0,36 |
1,50 |
|
guanosine 5′-monophosphate |
0,12 |
0,50 |
|
inosine 5′-monophosphate |
0,24 |
1,00 |
|
(1)
The total concentration of nucleotides shall not exceed 1,2 mg/100 kJ (5 mg/100 kcal). |
||
ANNEX II
COMPOSITIONAL REQUIREMENTS REFERRED TO IN ARTICLE 2(2)
1. ENERGY
|
Minimum |
Maximum |
|
250 kJ/100 ml |
293 kJ/100 ml |
|
(60 kcal/100 ml) |
(70 kcal/100 ml) |
2. PROTEINS
(Protein content = nitrogen content × 6,25)
2.1. Follow-on formula manufactured from cows' milk or goats' milk proteins
|
Minimum |
Maximum |
|
0,38 g/100 kJ |
0,6 g/100 kJ |
|
(1,6 g/100 kcal) |
(2,5 g/100 kcal) |
For an equal energy value, follow-on formula manufactured from cows' milk or goats' milk proteins must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine and the concentration of phenylalanine and tyrosine may be added together.
2.2. Follow-on formula manufactured from soya protein isolates, alone or in a mixture with cows' milk or goats' milk proteins
|
Minimum |
Maximum |
|
0,54 g/100 kJ |
0,67 g/100 kJ |
|
(2,25 g/100 kcal) |
(2,8 g/100 kcal) |
Only protein isolates from soya shall be used in manufacturing this follow-on formula.
For an equal energy value, follow-on formula manufactured from soya protein isolates, alone or in a mixture with cows' milk or goats' milk proteins, must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine and the concentration of phenylalanine and tyrosine may be added together.
2.3. Follow-on formula manufactured from protein hydrolysates
Follow-on formula manufactured from protein hydrolysates shall comply with the protein-related requirements provided under point 2.3.1, point 2.3.2, or point 2.3.3.
Protein-related requirements group A
Protein content
|
Minimum |
Maximum |
|
0,44 g/100 kJ |
0,67 g/100 kJ |
|
(1,86 g/100 kcal) |
(2,8 g/100 kcal) |
Protein source
Demineralised sweet whey protein derived from cows’ milk after enzymatic precipitation of caseins using chymosin, consisting of:
63 % caseino-glycomacropeptide free whey protein isolate with a minimum protein content of 95 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3 %; and
37 % sweet whey protein concentrate with a minimum protein content of 87 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3,5 %.
Protein processing
Two-stage hydrolysis process using a trypsin preparation with a heat-treatment step (from 3 to 10 minutes at 80 to 100 °C) between the two hydrolysis steps.
Indispensable and conditionally indispensable amino acids
For an equal energy value, follow-on formula manufactured from protein hydrolysates must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section B of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine and the concentration of phenylalanine and tyrosine may be added together.
Protein related requirements group B
Protein content
|
Minimum |
Maximum |
|
0,55 g/100 kJ |
0,67 g/100 kJ |
|
(2,3 g/100 kcal) |
(2,8 g/100 kcal) |
Protein source
Whey protein derived from cows’ milk, consisting of:
77 % acid whey, coming from whey protein concentrate with a protein content of 35 to 80 %;
23 % sweet whey, coming from demineralised sweet whey with a minimum protein content of 12,5 %.
Protein processing
The source material is hydrated and heated. Following the heat-treatment step, the hydrolysis is carried out at a pH of 7,5 to 8,5 and a temperature of 55 to 70 °C with the use of an enzyme mixture of a serine endopeptidase and a protease/peptidase complex. The food enzymes are inactivated in a heat treatment step (from 2 to 10 seconds at 120 to 150 °C) during the production process.
Indispensable and conditionally indispensable amino acids
For an equal energy value, follow-on formula manufactured from protein hydrolysates must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine and the concentration of phenylalanine and tyrosine may be added together.
Protein related requirements group C
Protein content
|
Minimum |
Maximum |
|
0,45 g/100 kJ |
0,67 g/100 kJ |
|
(1,9 g/100 kcal) |
(2,8 g/100 kcal) |
Protein source
Whey protein derived from cows’ milk, consisting of 100 % sweet whey protein concentrate with a minimum protein content of 80 %.
Protein processing
The source material is hydrated and heated. Prior to the hydrolysis, the pH is adjusted to 6,5–7,5 at a temperature of 50–65 °C. The hydrolysis is carried out with the use of an enzyme mixture of a serine endopeptidase and a metalloprotease. The food enzymes are inactivated in a heat treatment step (from 2 to 10 seconds at 110 to 140 °C) during the production process.
Indispensable and conditionally indispensable amino acids
For an equal energy value, follow-on formula manufactured from protein hydrolysates must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine and the concentration of phenylalanine and tyrosine may be added together.
|
2.4. |
In all cases, amino acids may be added to follow-on formula solely for the purpose of improving the nutritional value of the proteins, and only in the proportions necessary for that purpose. |
3. TAURINE
If added to follow-on formula, the amount of taurine shall not be greater than 2,9 mg/100 kJ (12 mg/100 kcal).
4. LIPIDS
|
Minimum |
Maximum |
|
1,1 g/100 kJ |
1,4 g/100 kJ |
|
(4,4 g/100 kcal) |
(6,0 g/100 kcal) |
|
4.1. |
The use of the following substances shall be prohibited:
—
sesame seed oil,
—
cotton seed oil.
|
|
4.2. |
The trans fatty acid content shall not exceed 3 % of the total fat content. |
|
4.3. |
The erucic acid content shall not exceed 0,4 % of the total fat content. |
|
4.4. |
Linoleic acid
|
|
4.5. |
Alpha-linolenic acid
|
|
4.6. |
Docosahexaenoic acid
|
|
4.7. |
Other long-chain (20 and 22 carbon atoms) polyunsaturated fatty acids may be added. In that case the content of long-chain polyunsaturated fatty acids shall not exceed 2 % of the total fat content for n-6 long-chain polyunsaturated fatty acids (1 % of the total fat content for arachidonic acid (20:4 n-6). The eicosapentaenoic acid (20:5 n-3) content shall not exceed that of docosahexaenoic (22:6 n-3) acid content. |
5. PHOSPHOLIPIDS
The amount of phospholipids in follow-on formula shall not be greater than 2 g/l.
6. CARBOHYDRATES
|
Minimum |
Maximum |
|
2,2 g/100 kJ |
3,3 g/100 kJ |
|
(9 g/100 kcal) |
(14 g/100 kcal) |
|
6.1. |
The use of ingredients containing gluten shall be prohibited. |
|
6.2. |
Lactose
Those minimum levels shall not apply to follow-on formula:
—
in which soya protein isolates represent more than 50 % of the total protein content, or
—
bearing the statement ‘lactose free’ in accordance with Article 9(2).
|
|
6.3. |
Sucrose, fructose, honey
Honey shall be treated to destroy spores of Clostridium botulinum. |
|
6.4. |
Glucose Glucose may only be added to follow-on formula manufactured from protein hydrolysates. If added, the glucose content shall not exceed 0,5 g/100 kJ (2 g/100 kcal). |
|
6.5. |
Glucose syrup or dried glucose syrup Glucose syrup or dried glucose syrup may be added to follow-on formula manufactured from cows' milk or goats' milk proteins or follow-on formula manufactured from soya protein isolates (alone or in a mixture with cows' milk or goats' milk proteins) only if its dextrose equivalent does not exceed 32. If glucose syrup or dried glucose syrup is added to these products, the glucose content resulting from glucose syrup or dried glucose syrup shall not exceed 0,2 g/100 kJ (0,84 g/100 kcal). The maximum glucose amounts laid down in point 6.4 shall apply if glucose syrup or dried glucose syrup is added to follow-on formula manufactured from protein hydrolysates. |
7. FRUCTO-OLIGOSACCHARIDES AND GALACTO-OLIGOSACCHARIDES
Fructo-oligosaccharides and galacto-oligosaccharides may be added to follow-on formula. In that case their content shall not exceed: 0,8 g/100 ml in a combination of 90 % oligogalactosyl-lactose and 10 % high molecular weight oligofructosyl-saccharose.
Other combinations and maximum levels of fructo-oligosaccharides and galacto-oligosaccharides may be used, provided that their suitability for infants is demonstrated in accordance with Article 3(3).
8. MINERAL SUBSTANCES
8.1. Follow-on formula manufactured from cows' milk or goats' milk proteins or protein hydrolysates
|
|
Per 100 kJ |
Per 100 kcal |
||
|
Minimum |
Maximum |
Minimum |
Maximum |
|
|
Sodium (mg) |
6 |
14,3 |
25 |
60 |
|
Potassium (mg) |
19,1 |
38,2 |
80 |
160 |
|
Chloride (mg) |
14,3 |
38,2 |
60 |
160 |
|
Calcium (mg) |
12 |
33,5 |
50 |
140 |
|
Phosphorus (mg) (1) |
6 |
21,5 |
25 |
90 |
|
Magnesium (mg) |
1,2 |
3,6 |
5 |
15 |
|
Iron (mg) |
0,14 |
0,48 |
0,6 |
2 |
|
Zinc (mg) |
0,12 |
0,24 |
0,5 |
1 |
|
Copper (μg) |
14,3 |
24 |
60 |
100 |
|
Iodine (μg) |
3,6 |
6,9 |
15 |
29 |
|
Selenium (μg) |
0,72 |
2 |
3 |
8,6 |
|
Manganese (μg) |
0,24 |
24 |
1 |
100 |
|
Molybdenum (μg) |
— |
3,3 |
— |
14 |
|
Fluoride (μg) |
— |
24 |
— |
100 |
|
(1)
Total phosphorus. |
||||
The calcium:available phosphorus molar ratio shall not be less than 1 nor greater than 2. The amount of available phosphorus shall be calculated as 80 % of total phosphorus for follow-on formula manufactured from cow's milk protein, goats' milk protein or protein hydrolysates.
8.2. Follow-on formula manufactured from soya protein isolates, alone or in a mixture with cows' milk or goats' milk proteins
All requirements of point 8.1 shall apply, except for those concerning iron, phosphorus and zinc, which shall be as follows:
|
|
Per 100 kJ |
Per 100 kcal |
||
|
Minimum |
Maximum |
Minimum |
Maximum |
|
|
Iron (mg) |
0,22 |
0,6 |
0,9 |
2,5 |
|
Phosphorus (mg) (1) |
7,2 |
24 |
30 |
100 |
|
Zinc (mg) |
0,18 |
0,3 |
0,75 |
1,25 |
|
(1)
Total phosphorus. |
||||
The calcium:available phosphorus molar ratio shall not be less than 1 nor greater than 2. The amount of available phosphorus shall be calculated as 70 % of total phosphorus for follow-on formula manufactured from soya protein isolates.
9. VITAMINS
|
|
Per 100 kJ |
Per 100 kcal |
||
|
Minimum |
Maximum |
Minimum |
Maximum |
|
|
Vitamin A (μg-RE) (1) |
16,7 |
27,2 |
70 |
114 |
|
Vitamin D (μg) |
0,48 |
0,72 |
2 |
3 |
|
Thiamine (μg) |
9,6 |
72 |
40 |
300 |
|
Riboflavin (μg) |
14,3 |
95,6 |
60 |
400 |
|
Niacin (mg) (2) |
0,1 |
0,36 |
0,4 |
1,5 |
|
Pantothenic acid (mg) |
0,1 |
0,48 |
0,4 |
2 |
|
Vitamin B6 (μg) |
4,8 |
41,8 |
20 |
175 |
|
Biotin (μg) |
0,24 |
1,8 |
1 |
7,5 |
|
Folate (μg-DFE) (3) |
3,6 |
11,4 |
15 |
47,6 |
|
Vitamin B12 (μg) |
0,02 |
0,12 |
0,1 |
0,5 |
|
Vitamin C (mg) |
0,96 |
7,2 |
4 |
30 |
|
Vitamin K (μg) |
0,24 |
6 |
1 |
25 |
|
Vitamin E (mg α-tocopherol) (4) |
0,14 |
1,2 |
0,6 |
5 |
|
(1)
Preformed vitamin A; RE = all trans retinol equivalent.
(2)
Preformed niacin.
(3)
Dietary folate equivalent: 1 μg DFE = 1 μg food folate = 0,6 μg folic acid from formula.
(4)
Based on vitamin E activity of RRR-α-tocopherol. |
||||
10. NUCLEOTIDES
The following nucleotides may be added:
|
|
Maximum (1) |
|
|
(mg/100 kJ) |
(mg/100 kcal) |
|
|
cytidine 5′-monophosphate |
0,60 |
2,50 |
|
uridine 5′-monophosphate |
0,42 |
1,75 |
|
adenosine 5′-monophosphate |
0,36 |
1,50 |
|
guanosine 5′-monophosphate |
0,12 |
0,50 |
|
inosine 5′-monophosphate |
0,24 |
1,00 |
|
(1)
The total concentration of nucleotides shall not exceed 1,2 mg/100 kJ (5 mg/100 kcal). |
||
ANNEX III
INDISPENSABLE AND CONDITIONALLY INDISPENSABLE AMINO ACIDS IN BREAST MILK
For the purposes of point 2 of Annexes I and II, breast milk shall be used as reference protein as set out in Sections A and B of this Annex, respectively.
A. ►M5 Infant formula and follow-on formula manufactured from cows’ milk or goats’ milk proteins and infant formula and follow-on formula manufactured from soya protein isolates, alone or in a mixture with cows’ milk or goats’ milk proteins and infant formula and follow-on formula manufactured from protein hydrolysates ◄
For the purposes of points 2.1, 2.2, 2.3.2 and 2.3.3 of Annexes I and II, the indispensable and conditionally indispensable amino acids in breast milk, expressed in mg per 100 kJ and 100 kcal, are the following:
|
|
Per 100 kJ (1) |
Per 100 kcal |
|
Cysteine |
9 |
38 |
|
Histidine |
10 |
40 |
|
Isoleucine |
22 |
90 |
|
Leucine |
40 |
166 |
|
Lysine |
27 |
113 |
|
Methionine |
5 |
23 |
|
Phenylalanine |
20 |
83 |
|
Threonine |
18 |
77 |
|
Tryptophan |
8 |
32 |
|
Tyrosine |
18 |
76 |
|
Valine |
21 |
88 |
|
(1)
1 kJ = 0,239 kcal. |
||
B. Infant formula and follow-on formula manufactured from protein hydrolysates
For the purposes of point 2.3.1 of Annexes I and II, the indispensable and conditionally indispensable amino acids in breast milk, expressed in mg per 100 kJ and 100 kcal, are the following:
ANNEX IV
ACTIVE SUBSTANCES REFERRED TO IN ARTICLE 4(3)
|
Chemical name of the parent compound of the substance (1) |
Maximum residue level (mg/kg) |
|
Cadusafos |
0,006 |
|
Demeton-S-methyl Demeton-S-methyl sulfone Oxydemeton-methyl |
0,006 |
|
Ethoprophos |
0,008 |
|
Fipronil |
0,004 |
|
Propineb |
0,006 |
|
(1)
The most updated residue definition applies as set out in the relevant Annexes II, III, IV or V to Regulation (EC) No 396/2005 (the residue definition is mentioned in brackets behind the parent compound of the substance). |
|
ANNEX V
ACTIVE SUBSTANCES REFERRED TO IN ARTICLE 4(4)
|
Chemical name of the parent compound of the substance (1) |
|
Aldrin Dieldrin Disulfoton Endrin Fensulfothion Fentin Haloxyfop Heptachlor Hexachlorobenzene Nitrofen Omethoate Terbufos. |
|
(1)
The most updated residue definition applies as set out in the relevant Annexes II, III, IV or V to Regulation (EC) No 396/2005 (the residue definition is mentioned in brackets behind the parent compound of the substance). |
ANNEX VI
NAMES REFERRED TO IN ARTICLE 5
PART A
Name referred to in Article 5(1)
The name of infant formula and follow-on formula other than infant formula and follow-on formula manufactured entirely from cows' milk or goats' milk proteins shall be respectively:
PART B
Name referred to in Article 5(2)
The name of infant formula and follow-on formula manufactured entirely from cows' milk or goats' milk proteins shall be respectively:
ANNEX VII
REFERENCE INTAKES REFERRED TO IN ARTICLE 7(7)
|
Nutrient |
Reference intake |
|
Vitamin A |
(μg) 400 |
|
Vitamin D |
(μg) 7 |
|
Vitamin E |
(mg TE) 5 |
|
Vitamin K |
(μg) 12 |
|
Vitamin C |
(mg) 45 |
|
Thiamine |
(mg) 0,5 |
|
Riboflavin |
(mg) 0,7 |
|
Niacin |
(mg) 7 |
|
Vitamin B6 |
(mg) 0,7 |
|
Folate |
(μg) 125 |
|
Vitamin B12 |
(μg) 0,8 |
|
Pantothenic acid |
(mg) 3 |
|
Biotin |
(μg) 10 |
|
Calcium |
(mg) 550 |
|
Phosphorus |
(mg) 550 |
|
Potassium |
(mg) 1 000 |
|
Sodium |
(mg) 400 |
|
Chloride |
(mg) 500 |
|
Iron |
(mg) 8 |
|
Zinc |
(mg) 5 |
|
Iodine |
(μg) 80 |
|
Selenium |
(μg) 20 |
|
Copper |
(mg) 0,5 |
|
Magnesium |
(mg) 80 |
|
Manganese |
(mg) 1,2 |